1. Home
  2. BHB vs ZNTL Comparison

BHB vs ZNTL Comparison

Compare BHB & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bar Harbor Bankshares Inc.

BHB

Bar Harbor Bankshares Inc.

HOLD

Current Price

$34.07

Market Cap

527.8M

Sector

Finance

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$4.04

Market Cap

468.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHB
ZNTL
Founded
1887
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.8M
468.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
BHB
ZNTL
Price
$34.07
$4.04
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$37.00
$6.60
AVG Volume (30 Days)
83.8K
4.4M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.95%
N/A
EPS Growth
N/A
18.03
EPS
2.31
N/A
Revenue
N/A
N/A
Revenue This Year
$22.68
N/A
Revenue Next Year
$3.66
N/A
P/E Ratio
$15.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.06
$1.13
52 Week High
$36.05
$6.95

Technical Indicators

Market Signals
Indicator
BHB
ZNTL
Relative Strength Index (RSI) 51.30 52.29
Support Level $33.87 $3.75
Resistance Level $35.61 $6.95
Average True Range (ATR) 0.75 0.42
MACD -0.09 -0.11
Stochastic Oscillator 18.01 13.15

Price Performance

Historical Comparison
BHB
ZNTL

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: